Nutcracker Therapeutics

Nutcracker Therapeutics is a biotechnology company dedicated to the development and production of mRNA therapeutics on its proprietary microfluidic and biochip-based platform. With just the press of a button, the company’s fully integrated system provides on-demand experimental and manufacturing capabilities that can be scaled as needed for the production of mRNA therapies, enabling healthcare companies to produce complex multimodal treatments at the point of care. By combining the productivity of RNA biology with semiconductor manufacturing technology, Nutcracker Therapeutics has developed a proprietary micro-platform that allows for the rapid discovery, development, and manufacture of mRNA therapies and vaccines. Its ACORN platform is the first computer-controlled RNA manufacturing system, which starts with the target nucleic acid sequence and produces optimized nanoparticle-encapsulated RNA therapeutics on a dedicated single-use biochip.